KRAS G12D + STK11 mutation
|
Lung Cancer
|
KRAS G12D + STK11 mutation
|
Lung Cancer
|
trametinib Sensitive: D – Preclinical
|
trametinib Sensitive: D – Preclinical
|
KRAS G12D + STK11 mutation
|
Lung Cancer
|
KRAS G12D + STK11 mutation
|
Lung Cancer
|
hydroxychloroquine Sensitive: D – Preclinical
|
hydroxychloroquine Sensitive: D – Preclinical
|
KRAS G12D + STK11 mutation
|
NSCLC
|
KRAS G12D + STK11 mutation
|
NSCLC
|
cisplatin Sensitive: D – Preclinical
|
cisplatin Sensitive: D – Preclinical
|